We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+7.68%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$57.8B
AUM Growth
-$3.34B
Cap. Flow
-$7.23B
Cap. Flow %
-12.51%
Top 10 Hldgs %
17.44%
Holding
2,351
New
173
Increased
825
Reduced
1,144
Closed
138

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$121M
2
GS icon
Goldman Sachs
GS
+$106M
3
CARR icon
Carrier Global
CARR
+$80.6M
4
MKL icon
Markel Group
MKL
+$79.9M
5
CB icon
Chubb
CB
+$77.6M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$339M
2
META icon
Meta Platforms (Facebook)
META
+$291M
3
MSFT icon
Microsoft
MSFT
+$290M
4
TGT icon
Target
TGT
+$207M
5
AAPL icon
Apple
AAPL
+$201M

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Consumer Discretionary 14.33%
3 Healthcare 13.82%
4 Industrials 11.74%
5 Financials 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NH
2201
DELISTED
NantHealth, Inc
NH
$69K ﹤0.01%
1,986
-1,909
-49% -$75.9K
SENS icon
2202
Senseonics Holdings Inc
SENS
$366M
$68K ﹤0.01%
+891
New +$45.1K
ATXS
2203
DELISTED
Astria Therapeutics
ATXS
$66K ﹤0.01%
5,232
-844
-14% -$11K
IDEX
2204
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$64K ﹤0.01%
+180
New +$64.3K
STR
2205
DELISTED
Sitio Royalties
STR
$61K ﹤0.01%
+2,980
New +$57.2K
ATNX
2206
DELISTED
Athenex, Inc. Common Stock
ATNX
$59K ﹤0.01%
+639
New +$58.1K
ABUS icon
2207
Arbutus Biopharma
ABUS
$915M
$58K ﹤0.01%
+19,036
New +$59K
AKBA icon
2208
Akebia Therapeutics
AKBA
$252M
$53K ﹤0.01%
14,019
-25,229
-64% -$84.9K
SVRA icon
2209
Savara
SVRA
$1.19B
$50K ﹤0.01%
+29,511
New +$53.1K
SCTL
2210
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$46K ﹤0.01%
19,996
-14,692
-42% -$37.3K
MBIO icon
2211
Mustang Bio
MBIO
$4.55M
$39K ﹤0.01%
16
-51
-76% -$125K
CTIC
2212
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$38K ﹤0.01%
15,365
EVFM
2213
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$36K ﹤0.01%
2,116
ACAD icon
2214
Acadia Pharmaceuticals
ACAD
$5.03B
-8,661
Closed -$223K
ADPT icon
2215
Adaptive Biotechnologies
ADPT
$3.97B
-18,721
Closed -$734K
AIV
2216
Aimco
AIV
$383M
-232,796
Closed -$1.43M
ALLK
2217
DELISTED
Allakos
ALLK
-8,408
Closed -$965K
ALNY icon
2218
Alnylam Pharmaceuticals
ALNY
$29.3B
-1,914
Closed -$269K
AQST icon
2219
Aquestive Therapeutics
AQST
$494M
-19,786
Closed -$103K
ASC icon
2220
Ardmore Shipping
ASC
$683M
-15,290
Closed -$69K
ASMB icon
2221
Assembly Biosciences
ASMB
$529M
-4,870
Closed -$269K
OPTU
2222
Optimum Communications Inc
OPTU
$301M
-15,126
Closed -$492K
AX icon
2223
Axos Financial
AX
$5.68B
-5,443
Closed -$256K
BAK icon
2224
Braskem
BAK
$913M
-24,729
Closed -$352K
BAND
2225
Bandwidth Inc
BAND
$1.61B
-3,546
Closed -$449K

Similar funds

AQR Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, AQR Capital Management held 2,351 positions worth $57.8B, down 5.5% from $61.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

AQR Capital Management withdrew a net $7.23B in Q2 2021, closing 138 positions and reducing 1,144 holdings. Its most notable exit was Extended Stay America, Inc. Paired Share Unit, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, AQR Capital Management opened a new position in Li Auto worth $26M.

  • AQR Capital Management's largest Q2 2021 buy was Li Auto: 743,909 shares worth $26M.
  • AQR Capital Management added most to JPMorgan Chase in Q2 2021, an estimated $121M increase.
  • AQR Capital Management's biggest Q2 2021 reduction was Amazon, cutting an estimated $339M.
  • AQR Capital Management fully exited Extended Stay America, Inc. Paired Share Unit in Q2 2021, selling an estimated $21.7M.
  • AQR Capital Management's ten largest holdings make up 17% of its $57.8B portfolio in Q2 2021.
  • AQR Capital Management opened 173 new positions and closed 138 in Q2 2021.
  • AQR Capital Management's portfolio value fell 5.5% quarter-over-quarter to $57.8B.

Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.